McKesson/Quintiles Info Services Venture Has Access To 40% Of U.S. Rxs
Executive Summary
The McKesson/Quintiles information services joint venture will have access to up to 40% of prescriptions, plus 20% of medical claims in the U.S
You may also be interested in...
Quintiles Rejects Buy-Out Offer From Founder Gillings, Weighs Options
Quintiles will look for potential buyers after rejecting an acquisition offer from founder and Chairman Dennis Gillings, PhD
Quintiles Rejects Buy-Out Offer From Founder Gillings, Weighs Options
Quintiles will look for potential buyers after rejecting an acquisition offer from founder and Chairman Dennis Gillings, PhD
Quintiles/Orion Rx Development Venture Will Start With Three Phase II Drugs
A drug development venture being formed by the contract research organization Quintiles and the Finnish drug manufacturer Orion will start with at least three drugs in Phase II clinical trials